Andrei Gudkov

Dr. Gudkov is a world-renowned cancer and longevity researcher. He is one of the pioneers in the field of cell senescence, elucidating the role of p53 and interferon in cancer, as well as the importance of the immune system in the clearance of genome-compromised cells. In the past decade, Dr. Gudkov has also focused on studying LINE-1 and other retroelements, and had suggested important insights about the role of retrobiome in genome instability that accompanies cancer and aging.

Additionally, Dr. Gudkov has been developing various aging biomarkers, such as multifactorial frailty indexes for humans and animals. In conjunction with being the CSO of GPI, Dr. Gudkov holds various positions at the Roswell Park Comprehensive Cancer Center where he serves as a Senior Vice President for Basic Research, a Chair of the Department of Cell Stress Biology, and a member of the senior leadership team for National Cancer Institute (NCI) Cancer Center Support Grant. At Roswell Park, Dr. Gudkov is leading the Cell Stress Biology program in DNA damage and repair, photodynamic therapy, thermal and hypoxic stress and immune modulation.

Previously Dr. Gudkov worked at the Lerner Research Institute, Cleveland Clinic Foundation where he served as a chair of the Department of Molecular Genetics and as a professor of biochemistry at Case Western University. He has authored or co-authored over 250 scientific articles and over 50 issued US patents. Dr. Gudkov holds a Ph.D. in Experimental Oncology from the Cancer Research Center and a Doctor of Science (D.Sc.) degree in Molecular Biology from the Moscow State University.